A detailed history of Hsbc Holdings PLC transactions in Amgen Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 1,887,565 shares of AMGN stock, worth $602 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,887,565
Previous 1,681,623 12.25%
Holding current value
$602 Million
Previous $478 Million 23.35%
% of portfolio
0.37%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $54.1 Million - $65.8 Million
205,942 Added 12.25%
1,887,565 $590 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $57.4 Million - $69.3 Million
213,578 Added 14.55%
1,681,623 $478 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $55.4 Million - $62.5 Million
216,588 Added 17.31%
1,468,045 $423 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $77.9 Million - $96.8 Million
-356,500 Reduced 22.17%
1,251,457 $336 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $44.2 Million - $52.3 Million
206,298 Added 14.72%
1,607,957 $357 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $37.7 Million - $46 Million
167,155 Added 13.54%
1,401,659 $339 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $88.3 Million - $112 Million
385,470 Added 45.4%
1,234,504 $324 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $12.8 Million - $14.4 Million
-56,992 Reduced 6.29%
849,034 $193 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $12.7 Million - $14.2 Million
-55,261 Reduced 5.75%
906,026 $221 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $7.27 Million - $8.04 Million
-33,149 Reduced 3.33%
961,287 $233 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $8.63 Million - $9.87 Million
-43,380 Reduced 4.18%
994,436 $224 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $31.4 Million - $36.8 Million
148,154 Added 16.65%
1,037,816 $222 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $3.76 Million - $4.17 Million
16,085 Added 1.84%
889,662 $217 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $24.4 Million - $28.4 Million
-109,786 Reduced 11.16%
873,577 $217 Million
Q4 2020

Feb 25, 2021

SELL
$216.38 - $257.67 $13.5 Million - $16 Million
-62,230 Reduced 5.95%
983,363 $226 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $55.3 Million - $65.9 Million
255,796 Added 32.39%
1,045,593 $240 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $3.22 Million - $3.59 Million
13,740 Added 1.77%
789,797 $200 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $1.96 Million - $2.41 Million
9,932 Added 1.3%
776,057 $183 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $16.7 Million - $22.2 Million
91,889 Added 13.63%
766,125 $157 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $14.4 Million - $18.5 Million
75,870 Added 12.68%
674,236 $162 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $11.5 Million - $13.8 Million
-65,964 Reduced 9.93%
598,366 $116 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $974,861 - $1.14 Million
-5,848 Reduced 0.87%
664,330 $122 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $26.9 Million - $30.3 Million
148,470 Added 28.46%
670,178 $127 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $33.6 Million - $39.2 Million
-188,292 Reduced 26.52%
521,708 $102 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $22.7 Million - $25.6 Million
122,687 Added 20.89%
710,000 $147 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $97.6 Million - $110 Million
-587,734 Reduced 50.02%
587,313 $108 Million
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $78.6 Million - $91.9 Million
-464,035 Reduced 28.31%
1,175,047 $200 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $92.2 Million - $103 Million
546,208 Added 49.98%
1,639,082 $285 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $25 Million - $28.5 Million
149,241 Added 15.82%
1,092,874 $204 Million
Q2 2017

Aug 14, 2017

BUY
N/A
943,633
943,633 $163 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.